Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 941-947, October 2006

Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting

  • Douglas J. Veale, MD, FRCPI, FRCP(Lon)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +353 1 2773721; Fax: +353 1 2839240.

Department of Rheumatology, St Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6942(06)00052-0

doi:10.1016/j.berh.2006.05.004

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 941-947, October 2006

Article Tools